Form EFFECT Inozyme Pharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 1, 2025 |
| Accession Number: | 0001193125-25-153585 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFI backs community-led research in the North with $10 million in investments
- This Father's Day, Healthy Moms, Healthy Babies America Calls on Fathers to Help End America's Maternal Health Crisis
- From Living Rooms to Garages: GARVEE Expands Affordable Cooling Solutions for Summer 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
